159 related articles for article (PubMed ID: 38245723)
1. Transforming growth factor-induced gene TGFBI is correlated with the prognosis and immune infiltrations of breast cancer.
Wang H; Wang X; Xu L
World J Surg Oncol; 2024 Jan; 22(1):22. PubMed ID: 38245723
[TBL] [Abstract][Full Text] [Related]
2. Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis.
Chiavarina B; Costanza B; Ronca R; Blomme A; Rezzola S; Chiodelli P; Giguelay A; Belthier G; Doumont G; Van Simaeys G; Lacroix S; Yokobori T; Erkhem-Ochir B; Balaguer P; Cavailles V; Fabbrizio E; Di Valentin E; Gofflot S; Detry O; Jerusalem G; Goldman S; Delvenne P; Bellahcène A; Pannequin J; Castronovo V; Turtoi A
Theranostics; 2021; 11(4):1626-1640. PubMed ID: 33408771
[TBL] [Abstract][Full Text] [Related]
3. Identification of transforming growth factor beta induced (TGFBI) as an immune-related prognostic factor in clear cell renal cell carcinoma (ccRCC).
Du GW; Yan X; Chen Z; Zhang RJ; Tuoheti K; Bai XJ; Wu HH; Liu TZ
Aging (Albany NY); 2020 May; 12(9):8484-8505. PubMed ID: 32406866
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer.
Palomeras S; Diaz-Lagares Á; Viñas G; Setien F; Ferreira HJ; Oliveras G; Crujeiras AB; Hernández A; Lum DH; Welm AL; Esteller M; Puig T
Breast Cancer Res; 2019 Jul; 21(1):79. PubMed ID: 31277676
[TBL] [Abstract][Full Text] [Related]
5. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.
Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H
Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803
[TBL] [Abstract][Full Text] [Related]
6. A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion.
Dai M; Al-Odaini AA; Arakelian A; Rabbani SA; Ali S; Lebrun JJ
Breast Cancer Res; 2012 Sep; 14(5):R127. PubMed ID: 22995475
[TBL] [Abstract][Full Text] [Related]
7. TGFBI modulates tumour hypoxia and promotes breast cancer metastasis.
Fico F; Santamaria-Martínez A
Mol Oncol; 2020 Dec; 14(12):3198-3210. PubMed ID: 33080107
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes.
Guo J; Canaff L; Rajadurai CV; Fils-Aimé N; Tian J; Dai M; Korah J; Villatoro M; Park M; Ali S; Lebrun JJ
Breast Cancer Res; 2014 Dec; 16(6):476. PubMed ID: 25499443
[TBL] [Abstract][Full Text] [Related]
9. Basal-like breast cancer with low TGFβ and high TNFα pathway activity is rich in activated memory CD4 T cells and has a good prognosis.
Liu D; Vadgama J; Wu Y
Int J Biol Sci; 2021; 17(3):670-682. PubMed ID: 33767579
[TBL] [Abstract][Full Text] [Related]
10. The transcriptional regulators TAZ and YAP direct transforming growth factor β-induced tumorigenic phenotypes in breast cancer cells.
Hiemer SE; Szymaniak AD; Varelas X
J Biol Chem; 2014 May; 289(19):13461-74. PubMed ID: 24648515
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.
Richards EJ; Zhang G; Li ZP; Permuth-Wey J; Challa S; Li Y; Kong W; Dan S; Bui MM; Coppola D; Mao WM; Sellers TA; Cheng JQ
J Biol Chem; 2015 Mar; 290(11):6857-67. PubMed ID: 25605728
[TBL] [Abstract][Full Text] [Related]
12. The role of TGFBI in mesothelioma and breast cancer: association with tumor suppression.
Li B; Wen G; Zhao Y; Tong J; Hei TK
BMC Cancer; 2012 Jun; 12():239. PubMed ID: 22695319
[TBL] [Abstract][Full Text] [Related]
13. High Stromal TGFBI in Lung Cancer and Intratumoral CD8-Positive T Cells were Associated with Poor Prognosis and Therapeutic Resistance to Immune Checkpoint Inhibitors.
Nakazawa N; Yokobori T; Kaira K; Turtoi A; Baatar S; Gombodorj N; Handa T; Tsukagoshi M; Ubukata Y; Kimura A; Kogure N; Ogata K; Maeno T; Sohda M; Yajima T; Shimizu K; Mogi A; Kuwano H; Saeki H; Shirabe K
Ann Surg Oncol; 2020 Mar; 27(3):933-942. PubMed ID: 31571056
[TBL] [Abstract][Full Text] [Related]
14. High stromal transforming growth factor β-induced expression is a novel marker of progression and poor prognosis in gastric cancer.
Suzuki M; Yokobori T; Gombodorj N; Yashiro M; Turtoi A; Handa T; Ogata K; Oyama T; Shirabe K; Kuwano H
J Surg Oncol; 2018 Nov; 118(6):966-974. PubMed ID: 30260476
[TBL] [Abstract][Full Text] [Related]
15. TGFBI expression reduces in vitro and in vivo metastatic potential of lung and breast tumor cells.
Wen G; Partridge MA; Li B; Hong M; Liao W; Cheng SK; Zhao Y; Calaf GM; Liu T; Zhou J; Zhang Z; Hei TK
Cancer Lett; 2011 Sep; 308(1):23-32. PubMed ID: 21561707
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of transforming growth factor beta-induced in circulating tumor cell subline from pancreatic cancer cell line.
Sato T; Muramatsu T; Tanabe M; Inazawa J
Cancer Sci; 2018 Nov; 109(11):3623-3633. PubMed ID: 30156359
[TBL] [Abstract][Full Text] [Related]
17. TGFβ-dependent induction of interleukin-11 and interleukin-8 involves SMAD and p38 MAPK pathways in breast tumor models with varied bone metastases potential.
Gupta J; Robbins J; Jilling T; Seth P
Cancer Biol Ther; 2011 Feb; 11(3):311-6. PubMed ID: 21099351
[TBL] [Abstract][Full Text] [Related]
18. Transforming Growth Factor-beta Regulation of Ephrin Type-A Receptor 4 Signaling in Breast Cancer Cellular Migration.
Hachim IY; Villatoro M; Canaff L; Hachim MY; Boudreault J; Haiub H; Ali S; Lebrun JJ
Sci Rep; 2017 Nov; 7(1):14976. PubMed ID: 29101386
[TBL] [Abstract][Full Text] [Related]
19. GATA3 transcription factor abrogates Smad4 transcription factor-mediated fascin overexpression, invadopodium formation, and breast cancer cell invasion.
Sun J; He H; Pillai S; Xiong Y; Challa S; Xu L; Chellappan S; Yang S
J Biol Chem; 2013 Dec; 288(52):36971-82. PubMed ID: 24235142
[TBL] [Abstract][Full Text] [Related]
20. Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.
Sin S; Bonin F; Petit V; Meseure D; Lallemand F; Bièche I; Bellahcène A; Castronovo V; de Wever O; Gespach C; Lidereau R; Driouch K
J Natl Cancer Inst; 2011 Sep; 103(17):1323-37. PubMed ID: 21832234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]